# Severe Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA)-Positive Granulomatosis With Polyangiitis

**Authors:** Sara Amer, Gizem Keles, Ami Shah, Nicole Melendez

PMC · DOI: 10.7759/cureus.88082 · Cureus · 2025-07-16

## TL;DR

A 50-year-old man with a history of heroin use and hepatitis C was diagnosed with p-ANCA-positive granulomatosis with polyangiitis after presenting with multi-system symptoms.

## Contribution

This case report highlights the diagnostic challenges and management complexities of p-ANCA-positive GPA in patients with significant comorbidities.

## Key findings

- The patient exhibited upper and lower respiratory tract and renal involvement consistent with GPA.
- Renal biopsy confirmed pauci-immune necrotizing crescentic glomerulonephritis with granulomatous inflammation.
- Treatment with glucocorticoids and rituximab was initiated due to the patient's hepatitis C history.

## Abstract

This case report describes a 50-year-old Caucasian male with a history of heroin use and hepatitis C who presented with upper respiratory tract, lower respiratory tract, and renal involvement, ultimately diagnosed with perinuclear antineutrophil cytoplasmic antibody (p-ANCA)-positive granulomatosis with polyangiitis (GPA). The patient initially presented to the emergency department with epigastric pain, leg pain, dyspnea, and hemoptysis, accompanied by recent ear infection, olfactory disturbances, and skin manifestations. Despite initial empiric treatment for suspected pneumonia, his condition rapidly deteriorated. Further investigation revealed elevated inflammatory markers, positive p-ANCA, and characteristic imaging findings including pulmonary nodules and cavitary lesions. Renal involvement was evident through hematuria and proteinuria, while ear, nose, and throat (ENT) examination showed chronic sinusitis and nasal crusting. Renal biopsy revealed pauci-immune necrotizing crescentic glomerulonephritis with evidence of granulomatous inflammation, serologic testing revealed p-ANCA positivity, and negative renal immunofluorescence microscopy results. Treatment was initiated with high-dose glucocorticoids and rituximab, considering the patient’s hepatitis C history. This case emphasizes the importance of considering GPA in patients with multi-system involvement, even with p-ANCA positivity, and highlights the complexities of managing patients with significant comorbidities.

## Linked entities

- **Diseases:** granulomatosis with polyangiitis (MONDO:0012105)

## Full-text entities

- **Diseases:** glomerulonephritis (MESH:D005921), pneumonia (MESH:D011014), GPA (MESH:D014890), pulmonary nodules (MESH:D055613), hemoptysis (MESH:D006469), ear infection (MESH:D010031), proteinuria (MESH:D011507), epigastric pain (MESH:D010146), hematuria (MESH:D006417), olfactory disturbances (MESH:D000857), sinusitis (MESH:D012852), hepatitis C (MESH:D019698), granulomatous inflammation (MESH:D007249), Renal involvement (MESH:C565423), cavitary lesions (MESH:C566924), dyspnea (MESH:D004417)
- **Chemicals:** rituximab (MESH:D000069283), heroin (MESH:D003932), Perinuclear Antineutrophil Cytoplasmic Antibody (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12357746/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12357746/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12357746/full.md

---
Source: https://tomesphere.com/paper/PMC12357746